HeartSciences Change in Accounts Payable 2022-2025 | HSCS

HeartSciences change in accounts payable from 2022 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
HeartSciences Annual Change in Accounts Payable
(Millions of US $)
2025 $0
2024 $0
2023 $0
2022 $0
2021 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.008B $0.000B
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $43.991B 53.84
Tempus AI (TEM) United States $13.179B 0.00
Doximity (DOCS) United States $12.725B 56.62
Hims & Hers Health (HIMS) United States $9.572B 78.43
IRhythm Technologies (IRTC) United States $5.461B 0.00
Hinge Health (HNGE) United States $4.399B 0.00
Privia Health (PRVA) United States $2.828B 209.46
Inspire Medical Systems (INSP) United States $2.771B 40.74
Heartflow (HTFL) $2.557B 0.00
Phreesia (PHR) United States $1.884B 0.00
Enovis (ENOV) United States $1.766B 9.34
10x Genomics (TXG) United States $1.744B 0.00
Omnicell (OMCL) United States $1.497B 28.84
Schrodinger (SDGR) United States $1.436B 0.00
Azenta (AZTA) United States $1.400B 61.08
Clover Health Investments (CLOV) United States $1.343B 0.00
Claritev (CTEV) United States $1.135B 0.00
Evolent Health (EVH) United States $1.134B 0.00
Fulgent Genetics (FLGT) United States $0.679B 0.00
Zepp Health (ZEPP) Netherlands $0.652B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.481B 0.00
Talkspace (TALK) United States $0.445B 133.00
Butterfly Network (BFLY) United States $0.405B 0.00
Carlsmed (CARL) United States $0.354B 0.00
TruBridge (TBRG) United States $0.300B 52.53
Outset Medical (OM) United States $0.247B 0.00
Health Catalyst (HCAT) United States $0.239B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.234B 0.00
Nyxoah SA (NYXH) Belgium $0.213B 0.00
KORU Medical Systems (KRMD) United States $0.195B 0.00
CapsoVision (CV) United States $0.175B 0.00
MDxHealth SA (MDXH) Belgium $0.168B 0.00
CareCloud (CCLD) United States $0.163B 7.38
American Well (AMWL) United States $0.111B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.077B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
Pulmonx (LUNG) United States $0.070B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
111 (YI) China $0.056B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Precipio (PRPO) United States $0.025B 0.00
PROFUSA (PFSA) United States $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00